HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oligosaccharide Le(a)-Le(x): a cell surface marker for carcinomas derived from embryonic endoderm.

Abstract
An immunohistochemical evaluation of Le(a)-Le(x) expression by adenocarcinomas of the biliary tree, pancreas, colon and stomach was undertaken as examples of epithelial tumors derived from embryonic endoderm. This complements previous studies showing that Lea-Lex was present on the cell surface of non-small cell lung carcinomas, some non-lung carcinomas, and is a prognostic marker for squamous cell lung carcinomas. All of the tumor specimen evaluated were positive and no expression of Le(a)-Le(x) was detected in derivatives of neural, connective or muscle tissues. These findings indicate that it could be informative to examine the biological significance of Le(a)-Le(x) not only in carcinogenesis but during embryogenesis, as well.
AuthorsP L Stranahan, J LaRoe, R McCombs, I Rahim, C W Kuhn, D E Pettijohn
JournalOncology reports (Oncol Rep) 1998 Jan-Feb Vol. 5 Issue 1 Pg. 235-9 ISSN: 1021-335X [Print] Greece
PMID9458328 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Biomarkers, Tumor
  • Lewis Blood Group Antigens
  • Lewis X Antigen
  • Oligosaccharides
  • lewis(a)-lewis(x)
Topics
  • Adenocarcinoma (pathology, surgery)
  • Biomarkers, Tumor (analysis)
  • Carcinoma, Non-Small-Cell Lung (pathology)
  • Colonic Neoplasms (pathology)
  • Embryo, Mammalian
  • Endoderm
  • Gallbladder Neoplasms (pathology)
  • Gastric Mucosa (pathology)
  • Humans
  • Immunohistochemistry (methods)
  • Intestinal Mucosa (pathology)
  • Lewis Blood Group Antigens
  • Lewis X Antigen
  • Lung Neoplasms (pathology)
  • Metaplasia
  • Neoplasms, Squamous Cell (pathology)
  • Oligosaccharides (analysis)
  • Pancreatic Neoplasms (pathology)
  • Prognosis
  • Stomach Neoplasms (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: